This depression drug could effectively reduce PTSD
In a recent study from Mount Sinai, researchers found that repeated intravenous (IV) ketamine infusions strongly reduce symptom severity in people with chronic post-traumatic...
Common Alzheimer’s drug could slower cognitive decline
Cholinesterase inhibitors are a group of drugs recommended for the treatment of Alzheimer's disease, but their effects on cognition have been debated.
In a new...
Help stop the spread of COVID-19 and protect your family
The COVID-19 pandemic requires that we remain vigilant in our daily lives until we can safely return to everyday activities.
We can each take some...
This common drug may prevent deadly inflammation in COVID-19
In a new study, researchers found that a widely available and inexpensive drug targeting inflammatory genes may reduce mortality in COVID-19.
They reported that the...
Majority of children with autism may be ‘doing well’
In a new study, researchers found that positive outcomes for children with autism spectrum disorder (ASD) are more common than previously thought.
This is is...
For women: The FDA gives tips to prevent heart disease
More women die from heart disease than from any other cause: about one in five American women, according to the Centers for Disease Control and...
Common bowel disease may increase your risk of mental problems
In a new study, researchers found inflammatory bowel disease is linked to an increased risk for psychiatric disorders and suicide attempts.
The research was conducted...
Fasting acts as diet catalyst in people with metabolic syndrome
One in four Germans suffers from metabolic syndrome.
Several of four diseases of affluence occur at the same time in this 'deadly quartet': obesity, high...
Apple Watch can monitor this health problem in people with heart disease
In a new study, researchers found that the Apple Watch in association with an iPhone can be used to monitor frailty in people with...
This study shows a new early sign of Alzheimer’s disease
Alzheimer’s disease is progressive and may emerge in the brain 20 to 30 years before diagnosis.
It is therefore very important to pinpoint biomarkers—that is,...